Log In
BCIQ
Print this Print this
 

AGIL-FA

  Manage Alerts
Collapse Summary General Information
Company Agilis Biotherapeutics LLC
Description 
Molecular Target Frataxin (FXN) (FRDA)
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentIND
Standard IndicationAtaxia
Indication DetailsTreat Friedreich's ataxia
Regulatory Designation U.S. - Orphan Drug (Treat Friedreich's ataxia)
PartnerIntrexon Corp.

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today